200 related articles for article (PubMed ID: 33951176)
1. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
[TBL] [Abstract][Full Text] [Related]
2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
3. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
Xu P; Ye X; Zhang Y; Yuan Q; Liu M; Wu Q; Ren G; Li D
J Diabetes Complications; 2015; 29(1):5-12. PubMed ID: 25456819
[TBL] [Abstract][Full Text] [Related]
4. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
[TBL] [Abstract][Full Text] [Related]
6. Control of hyperglycemia in male mice by leflunomide: mechanisms of action.
Chen J; Sun J; Doscas ME; Ye J; Williamson AJ; Li Y; Li Y; Prinz RA; Xu X
J Endocrinol; 2018 Apr; 237(1):43-58. PubMed ID: 29496905
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes.
Ge X; Chen C; Hui X; Wang Y; Lam KS; Xu A
J Biol Chem; 2011 Oct; 286(40):34533-41. PubMed ID: 21846717
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
9. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice.
Camacho RC; Zafian PT; Achanfuo-Yeboah J; Manibusan A; Berger JP
Eur J Pharmacol; 2013 Sep; 715(1-3):41-5. PubMed ID: 23831019
[TBL] [Abstract][Full Text] [Related]
10. [Expression and pharmacological evaluation of fusion protein FGF21-L-Fc].
Yao WB; Ren GP; Han Y; Cao HW; Gao HM; Kan FM; Wang Q; Li DS
Yao Xue Xue Bao; 2011 Jul; 46(7):787-92. PubMed ID: 22010347
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
Kim JH; Bae KH; Choi YK; Go Y; Choe M; Jeon YH; Lee HW; Koo SH; Perfield JW; Harris RA; Lee IK; Park KG
Diabetes Obes Metab; 2015 Feb; 17(2):161-9. PubMed ID: 25359298
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 secretion enhances glucose uptake in mono(2-ethylhexyl)phthalate-treated adipocytes.
Hsu JW; Yeh SC; Tsai FY; Chen HW; Tsou TC
Toxicol In Vitro; 2019 Sep; 59():246-254. PubMed ID: 31009676
[TBL] [Abstract][Full Text] [Related]
15. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity.
Arner P; Pettersson A; Mitchell PJ; Dunbar JD; Kharitonenkov A; Rydén M
FEBS Lett; 2008 May; 582(12):1725-30. PubMed ID: 18460341
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.
Ying L; Li N; He Z; Zeng X; Nan Y; Chen J; Miao P; Ying Y; Lin W; Zhao X; Lu L; Chen M; Cen W; Guo T; Li X; Huang Z; Wang Y
Cell Death Dis; 2019 Sep; 10(9):665. PubMed ID: 31511499
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
Li S; Wang N; Guo X; Li J; Zhang T; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():355-366. PubMed ID: 30227329
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
Yu D; Ye X; Wu Q; Li S; Yang Y; He J; Liu Y; Zhang X; Yuan Q; Liu M; Li D; Ren G
Endocrine; 2016 Jun; 52(3):527-40. PubMed ID: 26607153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
